Feasibility and safety of the i-Coapsys has been demonstrated in preclinical animal setting,43 and human initial experience has also been reported (Pedersen W. Failure Analysis for Percutaneous MV Repair Devices, TCT Meeting, San Francisco 2009). The Mardil BACE (Basal Annuloplasty of the Cardia Externally; Mardil, Inc., Morrisville, NC) is a wide band with an inflatable chamber that is slipped externally around the base of the beating heart without cardiopulmonary bypass. The chamber can be inflated by saline through subcutaneous Inhibitors,research,lifescience,medical ports, and their volume can be adjusted intra- and postoperatively,
thus remodeling the mitral valve annulus and sub-valvular apparatus. The surgical device seems effective in functional MR reduction,44 and a percutaneous development
has been announced. Direct Annuloplasty The implantation of devices Axitinib VEGFR1 directly into the mitral annulus more closely reproduces surgical annuloplasty. Only the posterior annulus Inhibitors,research,lifescience,medical is usually targeted, since the anterior annulus remains a more challenging structure due to the close vicinity of the aortic valve. Annular calcification, circumflex artery, and the potential for leaflet damage remain of concern for direct annuloplasty approach. The Accucinch System (Guided Delivery System, Santa Clara, USA) is designed Inhibitors,research,lifescience,medical to implant a series of anchor elements under the posterior mitral annulus, in the sub-valvular space,
from trigone to trigone. All anchors are connected by a cable that is used to cinch the annulus and the basal portion of the left ventricle. The Accucinch is delivered through a retrograde transfemoral route. The feasibility and the Inhibitors,research,lifescience,medical safety of the device have been shown in 10 patients, with no conversion to surgery and no 30-day major events; however, mitral regurgitation reduction was inconsistent, most probably due Inhibitors,research,lifescience,medical to the challenge of implanting the anchors from trigone to trigone and close enough to the annulus (Kleber F. GDS Accucinch Program inhibitor Ceritinib Update, TCT Meeting, Miami 2012). The Mitralign device (Mitralign, Tewksbury, GSK-3 USA) also uses a transfemoral retrograde approach to deliver pairs of pledgets connected with a suture. Each pledget pair can be cinched to achieve selective plications of the annulus. More than two pairs of pledgets can be implanted along the posterior annulus. A prospective, single arm feasibility and safety study is on-going to obtain CE mark. Available data reported that 36 patients have been enrolled, and 24 treated; 5 of them have reached 1 year follow-up. Although final results are not yet available, in the first 15 patients no procedural death and one pericardial tamponade occurred. After 1 year an average reduction of one grade of MR was observed along with minimal reduction in LV dimensions (Grube E.